Clinical trial
Donepezil HCl & Cognitive Deficits in Autism
NCT00047697 · University of Pittsburgh, Other · Completed
Key facts
| NCT number | NCT00047697 |
|---|---|
| Title | Donepezil HCl & Cognitive Deficits in Autism |
| Official title | Donepezil HCl: Treating Cognitive Deficits in Autism |
| Lead sponsor | University of Pittsburgh, Other |
| Collaborators | National Institute of Mental Health (NIMH) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Autistic Disorder |
| Intervention type | Drug |
| Interventions | Donepezil HCl, Placebo |
| Enrollment | 34 |
| Start date | Oct 1, 2002 |
| Primary completion | Aug 1, 2006 |
| Completion | Aug 1, 2006 |
| First posted | Oct 16, 2002 |
| Last update posted | Oct 5, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: